Literature DB >> 24611736

Characteristics of A20 gene polymorphisms in T-cell acute lymphocytic leukemia.

Lihua Zhu, Fan Zhang, Qi Shen, Shaohua Chen, Xu Wang, Liang Wang, Lijian Yang, Xiuli Wu, Suming Huang, Christian A Schmidt, Yangqiu Li.   

Abstract

A20 is a repressor of NF-κB and was recently shown to be frequently inactivated by deletions or mutations in several types of lymphomas including T-cell lymphoma. Little is known about the characteristics of A20 mutations in T-cell acute lymphoblastic leukemia (T-ALL). In this study, we analyzed A20 polymorphisms and characterized their features in 11 cases with T-ALL, 30 samples from healthy Chinese individuals, and 3 cells lines including CCRF-CEM, Molt-4, and Toledo cells. Two frequent A20 polymorphisms were found: a CCT deletion at position 12384 and a nucleotide exchange (A to C) at position 13751 (rs2307859 and rs661561). The homozygous form (CC) of rs661561 was detected in all 10 cases with detectable T-ALL, while only 80% (24/30) of the healthy controls had this genotype. We found one T-ALL case without the above frequent single-nucleotide polymorphisms (SNPs) in which a T to G mutation at position 12486 was found, which results in an amino acid exchange (Phe127Cys; rs2230926). Similar results were found in Molt-4 cells, which lack the frequent SNPs but have a heterozygous polymorphism at position 13749 (C > T) (rs5029948). Interestingly, the T-ALL case with the Phe127Cys mutation and Molt-4 cells demonstrated a high A20 copy number as measured by real-time polymerase chain reaction amplification with three primer sets that cover different regions of the A20 gene, corresponding to a high A20 and low NF-κB expression level. In conclusion, we characterized the features of A20 polymorphisms in T-ALL, and found that a low frequency A20 mutation, which was thought to be involved in malignant T-ALL development, might function differently in T cell lymphomas.

Entities:  

Keywords:  A20; Gene expression; NF-κB; Polymorphisms; T-ALL

Mesh:

Substances:

Year:  2014        PMID: 24611736     DOI: 10.1179/1607845414Y.0000000160

Source DB:  PubMed          Journal:  Hematology        ISSN: 1024-5332            Impact factor:   2.269


  6 in total

Review 1.  The role of aberrant proteolysis in lymphomagenesis.

Authors:  Anagh A Sahasrabuddhe; Kojo S J Elenitoba-Johnson
Journal:  Curr Opin Hematol       Date:  2015-07       Impact factor: 3.284

2.  Significant lethality following liver resection in A20 heterozygous knockout mice uncovers a key role for A20 in liver regeneration.

Authors:  P Studer; C G da Silva; J M Revuelta Cervantes; A Mele; E Csizmadia; J J Siracuse; S M Damrauer; C R Peterson; D Candinas; D M Stroka; A Ma; M Bhasin; C Ferran
Journal:  Cell Death Differ       Date:  2015-05-15       Impact factor: 15.828

3.  Characteristics of A20 gene polymorphisms and clinical significance in patients with rheumatoid arthritis.

Authors:  Lihua Zhu; Liang Wang; Xu Wang; Lingling Zhou; Ziwei Liao; Ling Xu; Huixia Wu; Jie Ren; Zhaoxia Li; Lijian Yang; Shaohua Chen; Bo Li; Xiuli Wu; Yi Zhou; Yangqiu Li
Journal:  J Transl Med       Date:  2015-07-05       Impact factor: 5.531

4.  Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia.

Authors:  Yu Ma; Ziwei Liao; Yi Xu; Ziyun Zhong; Xu Wang; Fan Zhang; Shaohua Chen; Lijian Yang; Gengxin Luo; Xin Huang; Suming Huang; Xiuli Wu; Yangqiu Li
Journal:  Eur J Med Res       Date:  2014-11-11       Impact factor: 2.175

5.  Genetic and Functional Associations with Decreased Anti-inflammatory Tumor Necrosis Factor Alpha Induced Protein 3 in Macrophages from Subjects with Axial Spondyloarthritis.

Authors:  Yiping Liu; Zhan Ye; Xiang Li; Jennifer L Anderson; Mike Khan; Douglas DaSilva; Marissa Baron; Deborah Wilson; Vera Bocoun; Lynn C Ivacic; Steven J Schrodi; Judith A Smith
Journal:  Front Immunol       Date:  2017-07-24       Impact factor: 7.561

6.  [Detection of promoter and 3' UTR mutation in A20 gene of a case with T cell lymphoma cell leukemia].

Authors:  L L Zhou; G X Luo; L H Zhu; Q Wei; Y Q Wei; R Feng; Y Q Li
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2018-10-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.